Halotestin: The Most Androgenic Oral AAS — Educational Reference
Last updated: March 2026
Fluoxymesterone (Halotestin) carries one of the highest androgenic ratings of any AAS — roughly 8.5× testosterone. Historically used by powerlifters before competition for aggression and strength, it is also among the most hepatotoxic oral AAS. This educational reference covers its extreme pharmacology, documented risks, and harm reduction context.
(vs testosterone = 100:100)
Oral, per day (max 4 weeks)
Short use windows only
📋 On this page
How Fluoxymesterone Works
Fluoxymesterone is a 17α-alkylated testosterone derivative with both a 9α-fluoro and 11β-hydroxy substitution, making it one of the most potent androgens ever synthesized — and one of the most toxic.
The 9α-fluoro and 11β-hydroxy modifications dramatically increase androgen receptor binding affinity and cannot be aromatized or 5α-reduced (or minimally so). This means essentially all androgenic activity is direct — no conversion to estrogen, no conversion to DHT needed. The result: extreme androgenic effects with minimal estrogenic side effects but severe androgenic ones (acne, aggression, hair loss, virilization).
Fluoxymesterone uniquely activates androgen receptors in the central nervous system — particularly the amygdala, hypothalamus, and prefrontal cortex. This produces the characteristic aggression, pain tolerance increase, and competitive drive that powerlifters sought. Clinical literature documents both desired competitive focus and problematic violent aggression. This CNS effect is dose-dependent and unpredictable at individual level.
Despite its extraordinary anabolic:androgenic ratio of ~1900:850, fluoxymesterone does NOT significantly aromatize to estrogen. Estrogenic side effects (water retention, gynecomastia) are minimal. However, this also means the "buffer" that estrogen provides for cardiovascular and bone health is absent. HDL cholesterol is severely suppressed.
As a 17α-alkylated compound at extreme androgenic potency, fluoxymesterone causes rapid and severe hepatic stress. ALT/AST elevation is expected even at low doses. Peliosis hepatis — blood-filled cysts in the liver — has been documented. Hepatocellular carcinoma risk increases with cumulative exposure. Cycle lengths exceeding 4 weeks are considered extremely dangerous.
What the Research Shows
Data from clinical trials, powerlifting literature, and pharmacological studies on fluoxymesterone.
Side Effects & Risks
Key Takeaways
- Anabolic:androgenic ratio ~1900:850 — among highest ever synthesized
- Does NOT aromatize — no estrogenic side effects
- Documented CNS aggression and competitive drive — sought by powerlifters
- Extremely hepatotoxic — 17α-alkylated with maximum androgenic stress
- 6–10 hour half-life allows for pre-competition timing
- Severe HDL suppression — major cardiovascular risk
- Maximum safe cycle: 2–4 weeks only
- Absolutely contraindicated in women
- Precise mechanism of CNS aggression at the receptor level
- Individual variation in psychological response — unpredictable
- Long-term hepatic risk threshold — may be cumulative across multiple cycles
- Whether liver support (TUDCA, NAC) adequately mitigates toxicity at typical doses
- Long-term cardiovascular outcome data in users
🛒 Liver & Cardiovascular Support
If using any 17α-alkylated compound — especially one as potent as Halotestin — liver support and frequent bloodwork are non-negotiable harm reduction measures.
Related Resources
Want the Complete Protocol Guide?
Dosing schedules, interaction warnings, and cycle protocols for 50+ compounds — all in one place.
Get the Guide →
This page is for educational and harm reduction purposes only. It is not medical advice. Fluoxymesterone (Halotestin) is a Schedule III controlled substance in the United States. It is banned by WADA and all major sports organizations. Halotestin carries EXTREME health risks including severe hepatotoxicity (peliosis hepatis, hepatocellular carcinoma), cardiovascular damage, and documented psychological effects including violent aggression. This compound is contraindicated in women. HighPeptides does not endorse or encourage the use of controlled substances. Consult a qualified physician before any decisions regarding hormone use.